These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 955840)

  • 1. Influences on the rate of absorption of the cholecystographic contrast medium iosumetic acid in man.
    Speck U; Clauss W; Blumenbach L; Albrecht A
    Invest Radiol; 1976; 11(4):315-8. PubMed ID: 955840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biliary excretion of three cholecystographic contrast agents in dogs: iocetamic acid, iopronic acid and iosumetic acid.
    Barnhart JL; Berk RN; Czuleger PC
    Invest Radiol; 1979; 14(1):79-87. PubMed ID: 158000
    [No Abstract]   [Full Text] [Related]  

  • 3. [The absorption of cholecystographic contrast media, following intraduodenal application; reasons for improved absorption due to sodium bicarbonate (author's transl)].
    Hofmann EF
    Rofo; 1975 Dec; 123(6):522-5. PubMed ID: 129405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and preliminary pharmacologic evaluation of a zwitterionic oral cholecystographic agent.
    Sovak M; Barnhart JL; Ranganathan R; Schulze PE; Siefert HM; Speck U
    Invest Radiol; 1981; 16(6):513-6. PubMed ID: 7319759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical and chemical aspects of residual contrast media in the intestine during oral cholecystography with Trijobil and Falignost].
    Quasdorf M; Becker C; Quasdorf G; Becker HW
    Radiol Diagn (Berl); 1977; 18(1):19-28. PubMed ID: 866607
    [No Abstract]   [Full Text] [Related]  

  • 6. Determinants of the rate of intestinal absorption of oral cholecystographic contrast agents in the dog jejunum.
    Janes JO; Dietschy JM; Berk RN; Loeb PM; Barnhart JL
    Gastroenterology; 1979 May; 76(5 Pt 1):970-7. PubMed ID: 155546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Results and conclusions from metabolic studies of I 131 -falignost].
    Barke R; Hieckel HG
    Radiol Diagn (Berl); 1972; 13(6):805-15. PubMed ID: 4657544
    [No Abstract]   [Full Text] [Related]  

  • 8. Urinary excretion of three oral cholecystographic agents in man.
    McChesney EW; Banks WF
    Proc Soc Exp Biol Med; 1965; 119(4):1027-30. PubMed ID: 5836001
    [No Abstract]   [Full Text] [Related]  

  • 9. TYROPANOATE SODIUM. A NEW ORAL CHOLECYSTOGRAPHIC MEDIUM.
    DAVIS JJ
    Rocky Mt Med J; 1964 Apr; 61():35-9. PubMed ID: 14137928
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparative clinical evaluation of a new oral cholecystographic medium, orabilex with telepaque.
    O'LACO JP; WILCOX WA
    Wis Med J; 1960 Apr; 59():249-51. PubMed ID: 14428090
    [No Abstract]   [Full Text] [Related]  

  • 11. Radiopaque contrast media. XXXVII-Iopronic acid, a new contrast medium for oral cholecystography: pharmacologic investigation.
    Tirone P; Rosati G
    Farmaco Prat; 1976 Aug; 31(8):397-412. PubMed ID: 955053
    [No Abstract]   [Full Text] [Related]  

  • 12. A new contrast agent for oral cholecystography: iopronic acid (Oravue).
    Pizzolato NF; Arcomano JP; Baum AE
    AJR Am J Roentgenol; 1978 May; 130(5):845-7. PubMed ID: 417581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Iodoxanic acid, a new oral cholecystographic contrast medium: comparison with iodopanoic acid].
    Orlandini I
    Radiol Med; 1970 Sep; 56(9):832-5. PubMed ID: 5210611
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effects of three oral cholecystographic agents on laboratory data. Clinical chemical determinations and urinary tests (author's transl)].
    Kasezawa N; Tazawa R; Urushibata S; Kobayashi M
    Rinsho Byori; 1974 Jun; 22(6):440-4. PubMed ID: 4472714
    [No Abstract]   [Full Text] [Related]  

  • 15. RENAL TOXICITY OF ORAL CHOLECYSTOGRAPHIC MEDIA. BUNAMIODYL SODIUM AND IOPANOIC ACID.
    WENNBERG JE; OKUN R; HINMAN EJ; NORTHCUTT RC; GRIEP RJ; WALKER WG
    JAMA; 1963 Nov; 186():461-7. PubMed ID: 14085024
    [No Abstract]   [Full Text] [Related]  

  • 16. The influence of digoxin particle size on absorption of digoxin and the effect of propantheline and metoclopramide.
    Johnson BF; O'Grady J; Bye C
    Br J Clin Pharmacol; 1978 May; 5(5):465-7. PubMed ID: 656287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative trial of two oral cholecystographic contrast media--iocetamic acid (Cholebrin) and iopanoic acid (Telepaque).
    Fielding JA; Whitehouse GH
    Clin Radiol; 1979 Jan; 30(1):45-8. PubMed ID: 154372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind study of oral cholecystographic media: orabilex and telepaque.
    MORGAN LA; PARKS RE
    Radiology; 1960 Mar; 74():436-41. PubMed ID: 14424118
    [No Abstract]   [Full Text] [Related]  

  • 19. CLINICAL COMPARISON OF THREE CHOLECYSTOGRAPHIC MEDIA.
    HURLEY DJ; FEORE DR
    J Can Assoc Radiol; 1963 Dec; 14():187-90. PubMed ID: 14086129
    [No Abstract]   [Full Text] [Related]  

  • 20. Cholecystography with orabilex (a new cholecystographic dye).
    KLEIN MM
    W V Med J; 1960 Mar; 56():102-3. PubMed ID: 14409694
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.